Ignite Creation Date:
2024-05-05 @ 11:19 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01307592
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2011-03-01
Brief Title:
Gemcitabine Hydrochloride Rituximab Oxaliplatin and Lenalidomide in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma
Sponsor:
Organization:
National Cancer Institute NCI